JSR

JSR Corporation specializes in the production and supply of a wide array of polymer materials. Its primary offerings include elastomers like synthetic rubbers, performance chemicals such as hybrid coating materials, and plastics products including ABS resins. Additionally, JSR develops semiconductor materials like photoresists and CMP materials, display materials for LCD panels, and life sciences products. Headquartered in Tokyo, Japan, the company was founded in 1957.

Eric Johnson

President, Representative Director and CEO

23 past transactions

CropIn

Series D in 2022
CropIn, founded in 2010, is a pioneer in the Agtech sector, offering an innovative platform known as the Intelligent Agriculture Cloud. This platform empowers stakeholders in the agricultural ecosystem to utilize digitization and artificial intelligence to enhance decision-making, increase efficiency, and promote sustainability. CropIn has partnered with over 250 customers and digitized 16 million acres of farmland, positively impacting the livelihoods of more than 7 million farmers. The company has amassed extensive farming data insights, covering 488 crops and 10,000 crop varieties across 56 countries, making it a leader in the global 'Ag-intelligence' movement. Its AI and machine learning solutions are specifically designed for the agricultural industry, enabling comprehensive monitoring and management of farm operations. By integrating information and communication technology with traditional farming practices, CropIn aims to improve both the financial and operational aspects of agriculture, ensuring quality and safety in food production.

Inpria

Acquisition in 2021
Inpria Corporation is a specialized manufacturer based in Corvallis, Oregon, focusing on the design, development, and production of EUV metal oxide photoresists for the semiconductor industry. Founded in 2007, Inpria has established itself as a pioneer in the use of inorganic photoresists and thin films for nanoscale patterning. The company's patented photo-condensed molecular oxides allow for the direct deposition of atomically smooth, dense, and photopatternable metal oxide films from solution. This innovation enhances performance while simplifying processing. Inpria's products are meticulously optimized to meet industry specifications related to resolution, sensitivity, and line width roughness, offering a comprehensive solution that includes photoresists, developers, and ancillary materials to support advanced semiconductor manufacturing.

Fluence Analytics

Venture Round in 2021
Fluence Analytics, Inc. is a manufacturer of industrial and laboratory monitoring solutions focused on the polymer and biopharmaceutical sectors. Established in 2012 and based in New Orleans, Louisiana, the company specializes in systems that provide continuous data streams to analyze and optimize polymer production processes. Its offerings include a manufacturing system for real-time analysis of polymers and a light scattering-based instrument that assesses the stability of therapeutic proteins as well as the quality of both natural and synthetic polymers. By combining these measurements with proprietary analytical tools, Fluence Analytics enables manufacturers to enhance process control and accelerate research and development. The company was previously known as Advanced Polymer Monitoring Technologies, Inc. before rebranding in April 2017.

Vedanta Biosciences

Series D in 2021
Vedanta Biosciences is a clinical-stage microbiome company focused on developing therapies for immune-mediated and infectious diseases using live bacteria derived from the human microbiome. The company designs orally delivered defined bacterial consortia, leveraging libraries of microbiome-derived strains, proprietary datasets from human interventional studies, and tools for selecting potent strains. Its platform encompasses consortium design and CGMP manufacturing of bacterially defined products, enabling physicians to access live bacteria drugs for autoimmune and inflammatory conditions. Headquartered in Cambridge, Massachusetts, Vedanta Biosciences aims to create a new category of oral therapies arising from defined bacterial communities grown from clonal cell banks.

Iridia

Series B in 2021
Iridia, Inc. is a nanotechnology company based in Carlsbad, California, specializing in innovative data storage solutions utilizing DNA. Founded in 2016, Iridia has developed a pioneering DNA-based data storage system that integrates DNA polymer synthesis technology with semiconductor fabrication and electronic nano-switches. This technology allows for the writing, storing, and reading of data in a highly efficient manner, significantly reducing infrastructure requirements and environmental impact. By employing a highly-parallel format, Iridia's solution offers the potential for exceptionally high-density data storage, making it a commercially attractive option for managing large volumes of data. Formerly known as Dodo OmniData, Inc., the company rebranded to Iridia, Inc. in March 2018.

AlphaICs

Series B in 2021
AlphaICs India Private Limited specializes in developing artificial intelligence system on a chip (SoC) solutions, offering purpose-built SoCs, FPGA boards, and deep learning chips for various applications. Founded in 2016 and based in Bengaluru, the company focuses on sectors such as home automation, healthcare wearables, industrial automation, drones, and IoT systems. AlphaICs is advancing AI computing with its patented RAP (Real AI Processing) technology, which is designed to enhance the performance of autonomous systems like self-driving cars, robotics, and intelligent cloud computing. The company emphasizes edge inference and edge learning technologies, enabling efficient AI processing with high performance, low power consumption, and minimal latency. This approach aims to support clients in accelerating AI workloads while optimizing data management and continuous learning capabilities at the edge.

Cambridge Quantum Computing

Venture Round in 2020
Cambridge Quantum Computing Limited is a quantum computing software company based in Cambridge, United Kingdom, with additional operations in London, Chessington, San Francisco, Washington D.C., and Tokyo. Founded in 2014, the company specializes in developing software tools that facilitate the commercialization of quantum technologies. Its key offerings include t|ket, a quantum development platform; EUMEN, which focuses on quantum chemistry; QML, dedicated to quantum machine learning; and IronBridge, aimed at enhancing cybersecurity through quantum methods. Cambridge Quantum Computing's mission is to create effective and accessible applications of quantum computing for a diverse range of corporate and government use cases, leveraging its expertise in quantum protocols and algorithms.

Inpria

Series C in 2020
Inpria Corporation is a specialized manufacturer based in Corvallis, Oregon, focusing on the design, development, and production of EUV metal oxide photoresists for the semiconductor industry. Founded in 2007, Inpria has established itself as a pioneer in the use of inorganic photoresists and thin films for nanoscale patterning. The company's patented photo-condensed molecular oxides allow for the direct deposition of atomically smooth, dense, and photopatternable metal oxide films from solution. This innovation enhances performance while simplifying processing. Inpria's products are meticulously optimized to meet industry specifications related to resolution, sensitivity, and line width roughness, offering a comprehensive solution that includes photoresists, developers, and ancillary materials to support advanced semiconductor manufacturing.

Carbon

Series E in 2019
Carbon, Inc. is a technology company based in Redwood City, California, that specializes in advanced digital manufacturing solutions. Founded in 2013, Carbon designs and manufactures a range of products, including its proprietary Digital Light Synthesis technology, which utilizes digital light projection and programmable liquid resins to create high-quality parts with superior mechanical properties and surface finishes. The company also offers SpeedCell, a connected manufacturing system that facilitates the consistent production of end-use parts at scale, along with automated solutions like the Smart Part Washer. Carbon provides various materials, such as rigid and flexible polyurethanes, cyanate esters, and epoxies, serving diverse industries including automotive, consumer products, dental, industrial, and life sciences. By leveraging its Continuous Liquid Interface Production Technology, Carbon enables manufacturers to pursue innovative business models, including mass customization and on-demand inventory, while reducing tooling costs and accelerating time to market.

Cambridge Quantum Computing

Funding Round in 2019
Cambridge Quantum Computing Limited is a quantum computing software company based in Cambridge, United Kingdom, with additional operations in London, Chessington, San Francisco, Washington D.C., and Tokyo. Founded in 2014, the company specializes in developing software tools that facilitate the commercialization of quantum technologies. Its key offerings include t|ket, a quantum development platform; EUMEN, which focuses on quantum chemistry; QML, dedicated to quantum machine learning; and IronBridge, aimed at enhancing cybersecurity through quantum methods. Cambridge Quantum Computing's mission is to create effective and accessible applications of quantum computing for a diverse range of corporate and government use cases, leveraging its expertise in quantum protocols and algorithms.

Mattrix Technologies

Series A in 2019
Founded in 2018, Mattrix Technologies specializes in developing and manufacturing full-aperture OLET (organic light emitting transistor) displays. Its innovative OLET technology addresses the backplane issue hindering widespread adoption of OLED displays, offering a high aperture ratio and simplified manufacturing process.

Vedanta Biosciences

Series C in 2019
Vedanta Biosciences is a clinical-stage microbiome company focused on developing therapies for immune-mediated and infectious diseases using live bacteria derived from the human microbiome. The company designs orally delivered defined bacterial consortia, leveraging libraries of microbiome-derived strains, proprietary datasets from human interventional studies, and tools for selecting potent strains. Its platform encompasses consortium design and CGMP manufacturing of bacterially defined products, enabling physicians to access live bacteria drugs for autoimmune and inflammatory conditions. Headquartered in Cambridge, Massachusetts, Vedanta Biosciences aims to create a new category of oral therapies arising from defined bacterial communities grown from clonal cell banks.

FLOSFIA

Corporate Round in 2019
FLOSFIA INC. is a Tokyo-based company that focuses on the development of corundum structured Gallium Oxide semiconductor power devices. Founded on March 31, 2011, the company emerged as a spin-off from research conducted at Kyoto University. FLOSFIA specializes in film-formation using mist chemical vapor deposition (CVD) techniques, leveraging the unique physical properties of gallium oxide (Ga2O3) to create high breakdown voltage and high efficiency power devices. The firm is dedicated to advancing low-loss power device technology, contributing to the evolution of semiconductor applications.

Absci

Series D in 2019
Absci is a drug and target discovery company that leverages deep learning AI and synthetic biology to enhance the therapeutic potential of proteins. Its Integrated Drug Creation Platform streamlines the process of identifying novel drug targets, discovering optimal biotherapeutic candidates, and generating the necessary cell lines for manufacturing. By combining biologic drug discovery and cell line development into a single, efficient workflow, Absci collaborates with biotech and pharmaceutical innovators to develop next-generation protein-based drugs. These innovations include Bionic Proteins, which feature nonstandard amino acids, and other unique drug designs that may be unattainable through conventional methods. Absci's mission is to facilitate the development of improved medicines by effectively translating innovative ideas into viable drugs.

Cambridge Quantum Computing

Funding Round in 2018
Cambridge Quantum Computing Limited is a quantum computing software company based in Cambridge, United Kingdom, with additional operations in London, Chessington, San Francisco, Washington D.C., and Tokyo. Founded in 2014, the company specializes in developing software tools that facilitate the commercialization of quantum technologies. Its key offerings include t|ket, a quantum development platform; EUMEN, which focuses on quantum chemistry; QML, dedicated to quantum machine learning; and IronBridge, aimed at enhancing cybersecurity through quantum methods. Cambridge Quantum Computing's mission is to create effective and accessible applications of quantum computing for a diverse range of corporate and government use cases, leveraging its expertise in quantum protocols and algorithms.

Carbon

Series D in 2017
Carbon, Inc. is a technology company based in Redwood City, California, that specializes in advanced digital manufacturing solutions. Founded in 2013, Carbon designs and manufactures a range of products, including its proprietary Digital Light Synthesis technology, which utilizes digital light projection and programmable liquid resins to create high-quality parts with superior mechanical properties and surface finishes. The company also offers SpeedCell, a connected manufacturing system that facilitates the consistent production of end-use parts at scale, along with automated solutions like the Smart Part Washer. Carbon provides various materials, such as rigid and flexible polyurethanes, cyanate esters, and epoxies, serving diverse industries including automotive, consumer products, dental, industrial, and life sciences. By leveraging its Continuous Liquid Interface Production Technology, Carbon enables manufacturers to pursue innovative business models, including mass customization and on-demand inventory, while reducing tooling costs and accelerating time to market.

Thermalin

Series A in 2017
Thermalin, Inc. is a biotechnology company based in Cleveland, Ohio, founded in 2010, that focuses on developing innovative insulin therapies for individuals with Type 1 and Type 2 diabetes. The company aims to transform the insulin and insulin delivery market, valued at $30 billion, through its cutting-edge, highly concentrated, ultra-rapid acting insulin and a novel glucose management system that is the size of a postage stamp. This insulin can also be utilized in existing insulin pumps, enhancing their efficiency. In addition to its lead program, Thermalin is exploring partnerships to create no-cold-chain basal and mix insulins, as well as glucose-responsive insulins. Its products are designed to be rapidly absorbing and do not require refrigeration, thereby reducing the burden of insulin therapy and improving patient adherence and health outcomes.

Lexi

Acquisition in 2017
LEXI Co., Ltd. is a Tokyo-based company that specializes in the development of medical software and hardware focused on scientific visualization and simulation. Established in 1988 and known previously as LEXI Data Co., Ltd., the firm became a subsidiary of JSR Corporation in 2017. LEXI offers innovative 3D pre-operative planning orthopedic software designed for total and partial hip and knee arthroplasties, as well as osteotomies. Their software is both CE-marked and FDA-cleared, demonstrating compliance with stringent regulatory standards, and is produced under an ISO 13485-certified quality management system. Installed in over 250 medical institutions throughout Japan, LEXI's technology aims to enhance surgical performance and improve patient quality of life, reflecting the company's commitment to advancing medical practices through cutting-edge technological solutions.

Inpria

Series B in 2017
Inpria Corporation is a specialized manufacturer based in Corvallis, Oregon, focusing on the design, development, and production of EUV metal oxide photoresists for the semiconductor industry. Founded in 2007, Inpria has established itself as a pioneer in the use of inorganic photoresists and thin films for nanoscale patterning. The company's patented photo-condensed molecular oxides allow for the direct deposition of atomically smooth, dense, and photopatternable metal oxide films from solution. This innovation enhances performance while simplifying processing. Inpria's products are meticulously optimized to meet industry specifications related to resolution, sensitivity, and line width roughness, offering a comprehensive solution that includes photoresists, developers, and ancillary materials to support advanced semiconductor manufacturing.

Light Polymers

Series B in 2017
Light Polymers Inc. is a polymers and materials company specializing in the synthesis and formulation of solutions based on self-aligning lyotropic liquid crystals. Founded in 2006 and headquartered in South San Francisco, California, with research and development capabilities in Silicon Valley and an applications center in Taiwan, the company focuses on applications in flat panel displays, LED lighting, smart glass, solar energy, flexible printed circuit films, and horticultural lighting. Light Polymers aims to address challenges faced in the flat panel display industry, particularly in the production of optical film polarizers, by providing innovative, thin, and cost-effective polarizers that enhance brightness and maintain high-definition display quality. Their materials are designed to streamline manufacturing processes, eliminate traditional bottlenecks, and meet the growing demand for ultra-high-resolution displays while minimizing power consumption.

Selexis

Acquisition in 2017
Selexis is a leading life sciences company specializing in the generation of mammalian cell lines, particularly through its proprietary suspension-adapted CHO-K1 technology. The company focuses on developing innovative cell line generation technologies that enhance the expression of recombinant proteins in mammalian cells. By providing specialized expertise and advanced solutions, Selexis supports scientists and biopharmaceutical companies in their efforts to advance scientific innovation into effective, life-saving medicines. Its work primarily facilitates the production of monoclonal antibodies and recombinant proteins, thereby accelerating drug development and manufacturing processes.

Carbon

Series C in 2016
Carbon, Inc. is a technology company based in Redwood City, California, that specializes in advanced digital manufacturing solutions. Founded in 2013, Carbon designs and manufactures a range of products, including its proprietary Digital Light Synthesis technology, which utilizes digital light projection and programmable liquid resins to create high-quality parts with superior mechanical properties and surface finishes. The company also offers SpeedCell, a connected manufacturing system that facilitates the consistent production of end-use parts at scale, along with automated solutions like the Smart Part Washer. Carbon provides various materials, such as rigid and flexible polyurethanes, cyanate esters, and epoxies, serving diverse industries including automotive, consumer products, dental, industrial, and life sciences. By leveraging its Continuous Liquid Interface Production Technology, Carbon enables manufacturers to pursue innovative business models, including mass customization and on-demand inventory, while reducing tooling costs and accelerating time to market.

Lehigh Technologies

Venture Round in 2014
Lehigh Technologies, Inc. is a specialty chemicals company that produces micronized rubber powders (MRPs) from end-of-life tires and post-industrial rubber. Founded in 2003 and based in Tucker, Georgia, with a subsidiary in Barcelona, Spain, the company operates the world’s largest MRP manufacturing plant, which has an annual production capacity of 140 million pounds. Lehigh’s product offerings include MicroDyne and PolyDyne, which are tailored for various applications such as high-performance tires, plastics, asphalt, construction materials, and consumer goods. The company also provides EkoDyne, Rheopave, and Zenoflex, which enhance the performance of rubber-based products. By transforming waste materials into high-performance, sustainable powders, Lehigh Technologies helps industries reduce costs and environmental impact while optimizing product performance. The firm is recognized for its research and development capabilities through its Application & Development Center, which focuses on advancing MRP applications across multiple sectors.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.